| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 4.34e-05 | 2 | 132 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.02e-04 | 44 | 132 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.14e-04 | 18 | 132 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 4.28e-04 | 5 | 132 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 4.28e-04 | 5 | 132 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | cyclase activity | 5.16e-04 | 24 | 132 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 5.84e-04 | 25 | 132 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 6.10e-04 | 103 | 132 | 5 | GO:0008276 | |
| GeneOntologyMolecularFunction | amylase activity | 6.39e-04 | 6 | 132 | 2 | GO:0016160 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 6.66e-04 | 105 | 132 | 5 | GO:0008170 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 8.91e-04 | 7 | 132 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 1.07e-03 | 68 | 132 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 1.13e-03 | 69 | 132 | 4 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 1.26e-03 | 71 | 132 | 4 | GO:0042054 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 1.66e-05 | 86 | 129 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 2.02e-05 | 89 | 129 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 3.38e-05 | 59 | 129 | 5 | GO:0045214 | |
| Domain | LAM_G_DOMAIN | 1.42e-04 | 38 | 131 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 1.74e-04 | 40 | 131 | 4 | PF02210 | |
| Domain | A/G_cyclase_CS | 2.13e-04 | 17 | 131 | 3 | IPR018297 | |
| Domain | LamG | 2.52e-04 | 44 | 131 | 4 | SM00282 | |
| Domain | - | 2.55e-04 | 18 | 131 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 2.55e-04 | 18 | 131 | 3 | IPR029787 | |
| Domain | Mib_Herc2 | 2.90e-04 | 4 | 131 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 2.90e-04 | 4 | 131 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 2.90e-04 | 4 | 131 | 2 | PF06701 | |
| Domain | Gal_mutarotase_N | 2.90e-04 | 4 | 131 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 2.90e-04 | 4 | 131 | 2 | PF16863 | |
| Domain | Guanylate_cyc | 3.01e-04 | 19 | 131 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 3.01e-04 | 19 | 131 | 3 | PS50125 | |
| Domain | A/G_cyclase | 3.01e-04 | 19 | 131 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 3.01e-04 | 19 | 131 | 3 | PS00452 | |
| Domain | CYCc | 3.01e-04 | 19 | 131 | 3 | SM00044 | |
| Domain | Alpha-amylase_C | 4.82e-04 | 5 | 131 | 2 | PF02806 | |
| Domain | A-amylase/branching_C | 4.82e-04 | 5 | 131 | 2 | IPR006048 | |
| Domain | Laminin_domII | 4.82e-04 | 5 | 131 | 2 | IPR010307 | |
| Domain | Laminin_aI | 4.82e-04 | 5 | 131 | 2 | IPR009254 | |
| Domain | Laminin_I | 4.82e-04 | 5 | 131 | 2 | PF06008 | |
| Domain | Laminin_II | 4.82e-04 | 5 | 131 | 2 | PF06009 | |
| Domain | Glycoside_hydrolase_SF | 5.19e-04 | 53 | 131 | 4 | IPR017853 | |
| Domain | Adcy_conserved_dom | 7.19e-04 | 6 | 131 | 2 | IPR009398 | |
| Domain | Glyco_hydro_31_AS | 7.19e-04 | 6 | 131 | 2 | IPR030458 | |
| Domain | DUF1053 | 7.19e-04 | 6 | 131 | 2 | PF06327 | |
| Domain | Glyco_hydro_13 | 7.19e-04 | 6 | 131 | 2 | IPR015902 | |
| Domain | Laminin_G | 7.32e-04 | 58 | 131 | 4 | IPR001791 | |
| Domain | Glyco_hydro_31 | 1.00e-03 | 7 | 131 | 2 | IPR000322 | |
| Domain | Glyco_hydro_13_cat_dom | 1.00e-03 | 7 | 131 | 2 | IPR006047 | |
| Domain | Glyco_hydro_31 | 1.00e-03 | 7 | 131 | 2 | PF01055 | |
| Domain | Alpha-amylase | 1.00e-03 | 7 | 131 | 2 | PF00128 | |
| Domain | Aamy | 1.00e-03 | 7 | 131 | 2 | SM00642 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.00e-03 | 7 | 131 | 2 | PS00129 | |
| Domain | EGF_LAM_2 | 1.19e-03 | 30 | 131 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.19e-03 | 30 | 131 | 3 | PS01248 | |
| Domain | AC_N | 1.33e-03 | 8 | 131 | 2 | IPR032628 | |
| Domain | Adcy | 1.33e-03 | 8 | 131 | 2 | IPR030672 | |
| Domain | Trefoil | 1.33e-03 | 8 | 131 | 2 | PF00088 | |
| Domain | LAMININ_IVA | 1.33e-03 | 8 | 131 | 2 | PS51115 | |
| Domain | Laminin_B | 1.33e-03 | 8 | 131 | 2 | PF00052 | |
| Domain | LamB | 1.33e-03 | 8 | 131 | 2 | SM00281 | |
| Domain | AC_N | 1.33e-03 | 8 | 131 | 2 | PF16214 | |
| Domain | Laminin_IV | 1.33e-03 | 8 | 131 | 2 | IPR000034 | |
| Domain | P_TREFOIL_2 | 1.70e-03 | 9 | 131 | 2 | PS51448 | |
| Domain | PD | 1.70e-03 | 9 | 131 | 2 | SM00018 | |
| Domain | EGF_Lam | 1.87e-03 | 35 | 131 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.87e-03 | 35 | 131 | 3 | PF00053 | |
| Domain | Laminin_EGF | 2.38e-03 | 38 | 131 | 3 | IPR002049 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.75e-05 | 9 | 110 | 3 | M47622 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 7.20e-05 | 90 | 110 | 6 | M835 | |
| Pubmed | USP34 PPFIBP1 SYNE1 KDM3B TAB2 SIK3 MED13L WNK1 ADCY6 HEPH ZNF462 NRXN1 WDR35 EHMT1 | 2.32e-13 | 225 | 133 | 14 | 12168954 | |
| Pubmed | POLE UBR4 KDM3B TAB2 ZNFX1 SIK3 ARID1B KMT2D IPO9 LZTS1 ZNF516 MIB1 EHMT1 CTNND2 ZNF281 CSPP1 | 3.37e-09 | 638 | 133 | 16 | 31182584 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 NSD2 POLE UBR4 NTSR1 OBSCN KDM3B LAMA5 MED13L WNK1 PLEKHG1 CELSR1 KMT2D ZNF516 EHMT1 PDZD8 AKAP13 WDR90 HERC2 IQGAP3 | 8.49e-09 | 1105 | 133 | 20 | 35748872 |
| Pubmed | CBLL1 NES SYNE1 UBR4 ZNFX1 SIK3 SMC2 ZEB2 ZNF462 NRXN1 LZTS1 ZNF516 EHMT1 SYN1 DLG2 BAIAP2 HERC2 CTNND2 | 3.13e-08 | 963 | 133 | 18 | 28671696 | |
| Pubmed | 1.49e-07 | 103 | 133 | 7 | 10574462 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 22956255 | ||
| Pubmed | 2.18e-07 | 4 | 133 | 3 | 21789219 | ||
| Pubmed | USP34 PPFIBP1 SYNE1 UBR4 FBXW4 ZNF521 ZNFX1 MED13L ZEB2 MIB1 RETREG1 PDZD8 PRMT2 DLG2 BAIAP2 HERC2 CTNND2 TBC1D23 ZNF439 | 4.72e-07 | 1285 | 133 | 19 | 35914814 | |
| Pubmed | USP34 NSD2 VPS13C KDM3B LAMA5 SIK3 HEPH ARID1B ZNF516 MIB1 EHMT1 WDR90 | 9.82e-07 | 529 | 133 | 12 | 14621295 | |
| Pubmed | Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. | 1.08e-06 | 6 | 133 | 3 | 20081857 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.24e-06 | 220 | 133 | 8 | 35785414 | |
| Pubmed | SYNE1 OBSCN MYOZ2 LAMA2 TAB2 WNK1 ZNF462 ARID1B NPHP3 RETREG1 SON | 3.58e-06 | 497 | 133 | 11 | 23414517 | |
| Pubmed | KNTC1 USP34 NES ATP7B VPS13C KDM3B TMOD3 WNK1 ARID1B AMOTL1 PDZD8 AKAP13 BAIAP2 | 5.12e-06 | 733 | 133 | 13 | 34672954 | |
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 6.43e-06 | 10 | 133 | 3 | 20976766 | |
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 25266655 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 8.90e-06 | 351 | 133 | 9 | 38297188 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KNTC1 KRT9 ATP6V1G2 VPS13C OBSCN SIK3 PLEKHG1 NPHP3 IPO9 WDR35 IQGAP3 | 1.18e-05 | 564 | 133 | 11 | 21565611 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.35e-05 | 202 | 133 | 7 | 33005030 | |
| Pubmed | 1.39e-05 | 469 | 133 | 10 | 27634302 | ||
| Pubmed | The clinical significance of small copy number variants in neurodevelopmental disorders. | 1.45e-05 | 2 | 133 | 2 | 25106414 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 16226104 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31009605 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19534432 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19403693 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 17068292 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31162142 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 20431059 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 21593590 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 1.45e-05 | 2 | 133 | 2 | 19734365 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22567929 | ||
| Pubmed | Circular RNA WHSC1 exerts oncogenic properties by regulating miR-7/TAB2 in lung cancer. | 1.45e-05 | 2 | 133 | 2 | 34551195 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29036642 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31253481 | ||
| Pubmed | Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. | 1.45e-05 | 2 | 133 | 2 | 21282557 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 10481931 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 1.52e-05 | 13 | 133 | 3 | 21900571 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CBLL1 NES KRT9 NSD2 SYNE1 PPIL4 ZNF521 SIK3 HNRNPD ZNF462 ARID1B NRXN1 EHMT1 ZNF281 SON | 1.78e-05 | 1082 | 133 | 15 | 38697112 |
| Pubmed | 3.57e-05 | 17 | 133 | 3 | 21983115 | ||
| Pubmed | PPFIBP1 POLE KDM3B ZNFX1 SIK3 SMC2 ADCY6 WASH6P AKAP13 SLC12A7 IQGAP3 | 4.30e-05 | 650 | 133 | 11 | 38777146 | |
| Pubmed | Induction of Mutant Sik3Sleepy Allele in Neurons in Late Infancy Increases Sleep Need. | 4.34e-05 | 3 | 133 | 2 | 33558433 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 24318988 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 23569325 | ||
| Pubmed | Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. | 4.34e-05 | 3 | 133 | 2 | 16973443 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 27826057 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 21055905 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 36424917 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 10364433 | ||
| Pubmed | Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells. | 4.34e-05 | 3 | 133 | 2 | 19889965 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31882770 | ||
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 31173603 | ||
| Pubmed | ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies. | 4.34e-05 | 3 | 133 | 2 | 26788497 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 33155406 | ||
| Pubmed | Chromosomal mapping of human adenylyl cyclase genes type III, type V and type VI. | 4.34e-05 | 3 | 133 | 2 | 8034296 | |
| Pubmed | 4.34e-05 | 3 | 133 | 2 | 24357727 | ||
| Pubmed | Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor. | 4.34e-05 | 3 | 133 | 2 | 17593019 | |
| Pubmed | PPFIBP1 SYNE1 POLE UBR4 SIK3 MRPL2 PLEKHG1 MIB1 RETREG1 EHMT1 OCIAD2 PDZD8 AKAP13 BAIAP2 HERC2 CSPP1 DHX29 | 5.51e-05 | 1487 | 133 | 17 | 33957083 | |
| Pubmed | CBLL1 SP3 NSD2 PPFIBP1 SYNE1 LAMA5 LIN9 RIF1 CELSR1 EHMT1 BAIAP2 HERC2 CTNND2 ZNF281 DHX29 IQGAP3 SON | 5.98e-05 | 1497 | 133 | 17 | 31527615 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 NES POLE UBR4 PPIL4 SMC2 HNRNPD TGM3 RIF1 IPO9 MIB1 AKAP13 HERC2 ZNF281 DHX29 SON | 6.25e-05 | 1353 | 133 | 16 | 29467282 |
| Pubmed | 6.73e-05 | 110 | 133 | 5 | 14667819 | ||
| Pubmed | IL16 PPFIBP1 UBR4 TMOD3 TAB2 SIK3 IPO9 AMOTL1 ZNF516 MIB1 AKAP13 | 7.24e-05 | 689 | 133 | 11 | 36543142 | |
| Pubmed | Distinct fibroblast lineages determine dermal architecture in skin development and repair. | 7.98e-05 | 22 | 133 | 3 | 24336287 | |
| Pubmed | 8.66e-05 | 116 | 133 | 5 | 30804394 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 12270917 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 21089229 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 37074924 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 25049074 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 32620754 | ||
| Pubmed | Recurrent CNVs disrupt three candidate genes in schizophrenia patients. | 8.67e-05 | 4 | 133 | 2 | 18940311 | |
| Pubmed | beta1 integrin maintains integrity of the embryonic neocortical stem cell niche. | 8.67e-05 | 4 | 133 | 2 | 19688041 | |
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 28469556 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 10332026 | ||
| Pubmed | 8.67e-05 | 4 | 133 | 2 | 23451271 | ||
| Pubmed | An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | 8.67e-05 | 4 | 133 | 2 | 11565031 | |
| Pubmed | KNTC1 DACH1 KDM3B GBE1 MED13L SMC2 LIN9 ZEB2 HNRNPD ARID1B KMT2D ZNF516 EHMT1 ZNF281 | 8.85e-05 | 1103 | 133 | 14 | 34189442 | |
| Pubmed | 8.91e-05 | 272 | 133 | 7 | 31010829 | ||
| Pubmed | 9.69e-05 | 591 | 133 | 10 | 15231748 | ||
| Pubmed | 1.11e-04 | 486 | 133 | 9 | 20936779 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 NSD2 VPS13C SYNE1 POLE UBR4 PPIL4 SMC2 HNRNPD TGM3 RIF1 IPO9 EHMT1 DHX29 IQGAP3 MGAM2 | 1.14e-04 | 1425 | 133 | 16 | 30948266 |
| Pubmed | UBR4 PPIL4 DACH1 ZNF521 TMOD3 LIN9 ZEB2 MRPL2 ZNF462 RIF1 ARID1B KMT2D ZNF516 EHMT1 HERC2 ZNF281 | 1.18e-04 | 1429 | 133 | 16 | 35140242 | |
| Pubmed | KDM3B SIK3 WNK1 ADAM12 CAPN13 TGM3 FUT11 ARID1B ATP8A1 EHMT1 PRMT2 | 1.20e-04 | 730 | 133 | 11 | 34857952 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.22e-04 | 608 | 133 | 10 | 36089195 | |
| Pubmed | 1.24e-04 | 493 | 133 | 9 | 15368895 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 1.30e-04 | 67 | 133 | 4 | 34644545 | |
| Pubmed | Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. | 1.30e-04 | 67 | 133 | 4 | 23263486 | |
| Pubmed | 1.33e-04 | 26 | 133 | 3 | 22992956 | ||
| Pubmed | 1.38e-04 | 128 | 133 | 5 | 23858473 | ||
| Pubmed | 1.38e-04 | 128 | 133 | 5 | 30995482 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 11969289 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 1.44e-04 | 5 | 133 | 2 | 9415429 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 9271224 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 1.44e-04 | 5 | 133 | 2 | 9389447 | |
| Pubmed | Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles. | 1.44e-04 | 5 | 133 | 2 | 10024132 | |
| Pubmed | Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. | 1.44e-04 | 5 | 133 | 2 | 15582318 | |
| Pubmed | Basal enrichment within neuroepithelia suggests novel function(s) for Celsr1 protein. | 1.44e-04 | 5 | 133 | 2 | 20353824 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 21228062 | ||
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 11829758 | ||
| Pubmed | Genetic Associations with Gestational Duration and Spontaneous Preterm Birth. | 1.44e-04 | 5 | 133 | 2 | 28877031 | |
| Pubmed | 1.44e-04 | 5 | 133 | 2 | 14630787 | ||
| Pubmed | ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. | 1.44e-04 | 5 | 133 | 2 | 12771217 | |
| Interaction | TEAD1 interactions | 2.59e-06 | 176 | 133 | 9 | int:TEAD1 | |
| Interaction | NFIX interactions | 2.02e-05 | 227 | 133 | 9 | int:NFIX | |
| Interaction | TLX1 interactions | 2.15e-05 | 175 | 133 | 8 | int:TLX1 | |
| Interaction | GSC interactions | 2.40e-05 | 87 | 133 | 6 | int:GSC | |
| Interaction | MYB interactions | 2.90e-05 | 133 | 133 | 7 | int:MYB | |
| Interaction | PAX6 interactions | PPIL4 DACH1 ZNF521 LIN9 ZEB2 ZNF462 ARID1B KMT2D ZNF516 EHMT1 ZNF281 | 3.19e-05 | 366 | 133 | 11 | int:PAX6 |
| Interaction | TNIK interactions | NES SYNE1 TAB2 ZEB2 ZNF462 LZTS1 EHMT1 DLG2 BAIAP2 HERC2 CTNND2 | 4.59e-05 | 381 | 133 | 11 | int:TNIK |
| Interaction | FEV interactions | 6.17e-05 | 203 | 133 | 8 | int:FEV | |
| Cytoband | 6q25.1 | 4.60e-06 | 38 | 133 | 4 | 6q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 1.22e-04 | 164 | 133 | 5 | chr6q25 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.94e-04 | 34 | 97 | 3 | 487 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.25e-03 | 10 | 97 | 2 | 53 | |
| GeneFamily | Laminin subunits | 1.82e-03 | 12 | 97 | 2 | 626 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.59e-03 | 51 | 97 | 3 | 870 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.12e-03 | 18 | 97 | 2 | 1160 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.12e-03 | 18 | 97 | 2 | 91 | |
| GeneFamily | Sialyltransferases | 5.08e-03 | 20 | 97 | 2 | 438 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 SP3 ZNF521 ZEB2 ZNF490 ZNF462 ZNF516 ZNF439 ZNF281 ZNF554 | 5.14e-03 | 718 | 97 | 10 | 28 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.36e-03 | 66 | 97 | 3 | 722 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 1.51e-06 | 158 | 133 | 8 | M372 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.99e-06 | 180 | 133 | 8 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 5.14e-06 | 86 | 133 | 6 | M39247 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NES AMY2B DACH1 ITGA8 TMOD3 EBF1 ITGA9 PARP14 ZEB2 PLEKHG1 TMEM106B FUT11 PTPRJ AMOTL1 RETREG1 SON | 1.16e-05 | 888 | 133 | 16 | MM1018 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.32e-05 | 212 | 133 | 8 | M39221 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 SP3 IL16 VPS13C SYNE1 UBR4 TAB2 ZNFX1 SIK3 PARP14 WNK1 ZEB2 RIF1 KMT2D ATP8A1 PTPRJ RETREG1 PRMT2 AKAP13 TMEM123 SON | 2.03e-05 | 1492 | 133 | 21 | M40023 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.78e-05 | 171 | 133 | 7 | M39234 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NES DACH1 ITGA8 TMOD3 EBF1 ITGA9 PARP14 ZEB2 PLEKHG1 TMEM106B FUT11 PTPRJ AMOTL1 RETREG1 SON | 2.99e-05 | 854 | 133 | 15 | M1533 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ST6GALNAC1 KNTC1 CFAP36 VPS13C PPIL4 SMC2 RIF1 SEC62 RETREG1 CTNND2 CSPP1 DHX29 SON | 3.07e-05 | 656 | 133 | 13 | M18979 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 3.46e-05 | 177 | 133 | 7 | M39245 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 4.43e-05 | 184 | 133 | 7 | M9005 | |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 6.39e-05 | 195 | 133 | 7 | M7310 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP | 7.04e-05 | 198 | 133 | 7 | M5222 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 7.27e-05 | 137 | 133 | 6 | M39241 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 7.49e-05 | 200 | 133 | 7 | M387 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | ST6GALNAC1 NES PPFIBP1 DACH1 LAMA5 EBF1 PALMD PLEKHG1 OCIAD2 MX1 | 8.63e-05 | 440 | 133 | 10 | M39039 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.02e-05 | 206 | 133 | 7 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.58e-05 | 208 | 133 | 7 | MM581 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 USP34 SP3 KDM3B GBE1 TAB2 SIK3 MED13L ZEB2 RIF1 SOCS5 FGF5 AKAP13 SON | 1.19e-04 | 856 | 133 | 14 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.43e-04 | 155 | 133 | 6 | M39246 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | MGAM BNC2 SP3 NSD2 EBF1 SMC2 ZEB2 ZNF462 RIF1 MIB1 FGF5 CSPP1 | 8.57e-06 | 417 | 128 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.05e-10 | 200 | 133 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-09 | 159 | 133 | 9 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.63e-09 | 184 | 133 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 6.12e-09 | 190 | 133 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.12e-09 | 190 | 133 | 9 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.41e-09 | 191 | 133 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.57e-09 | 200 | 133 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.57e-09 | 200 | 133 | 9 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.57e-09 | 200 | 133 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 170 | 133 | 8 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-08 | 170 | 133 | 8 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.88e-08 | 185 | 133 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.64e-08 | 187 | 133 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.00e-07 | 188 | 133 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.05e-07 | 189 | 133 | 8 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.09e-07 | 190 | 133 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-07 | 192 | 133 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.23e-07 | 193 | 133 | 8 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.33e-07 | 195 | 133 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.44e-07 | 197 | 133 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-07 | 200 | 133 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-07 | 166 | 133 | 7 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-07 | 166 | 133 | 7 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-07 | 170 | 133 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-07 | 170 | 133 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-06 | 176 | 133 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 178 | 133 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-06 | 179 | 133 | 7 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 1.19e-06 | 180 | 133 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-06 | 181 | 133 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.23e-06 | 181 | 133 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.33e-06 | 183 | 133 | 7 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-06 | 184 | 133 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-06 | 184 | 133 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 186 | 133 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 187 | 133 | 7 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-06 | 188 | 133 | 7 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-06 | 188 | 133 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.64e-06 | 189 | 133 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.70e-06 | 190 | 133 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 1.70e-06 | 190 | 133 | 7 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-06 | 190 | 133 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-06 | 191 | 133 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 192 | 133 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 193 | 133 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-06 | 193 | 133 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-06 | 193 | 133 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 193 | 133 | 7 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-06 | 194 | 133 | 7 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 194 | 133 | 7 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.02e-06 | 195 | 133 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 196 | 133 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 196 | 133 | 7 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-06 | 196 | 133 | 7 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-06 | 197 | 133 | 7 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.17e-06 | 197 | 133 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-06 | 198 | 133 | 7 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 199 | 133 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.32e-06 | 199 | 133 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 2.32e-06 | 199 | 133 | 7 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 2.32e-06 | 199 | 133 | 7 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | 1029f3458b7fda464aa0e7ef06e081e2618c1388 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 199 | 133 | 7 | 8a04398653a1794921d73a6a950c1fb6fdf68c85 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.32e-06 | 199 | 133 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-06 | 200 | 133 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.39e-06 | 200 | 133 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.39e-06 | 200 | 133 | 7 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-06 | 200 | 133 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.39e-06 | 200 | 133 | 7 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.39e-06 | 200 | 133 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-06 | 157 | 133 | 6 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.70e-06 | 160 | 133 | 6 | 7db30647b596f0c419087e6fabb9b99dcd5bddd4 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.70e-06 | 160 | 133 | 6 | 01f22cdb2a2f73776b7f91746e95c1850df94235 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.01e-06 | 161 | 133 | 6 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 161 | 133 | 6 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.67e-06 | 163 | 133 | 6 | 218b9ba099cb27aa91c6b73bf89b44895f5dddc3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 164 | 133 | 6 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.11e-05 | 167 | 133 | 6 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-05 | 170 | 133 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 172 | 133 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 172 | 133 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.36e-05 | 173 | 133 | 6 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.36e-05 | 173 | 133 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.36e-05 | 173 | 133 | 6 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-05 | 175 | 133 | 6 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.59e-05 | 178 | 133 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 178 | 133 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | wk_08-11-Epithelial-PNS-Proliferating_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 179 | 133 | 6 | ab23fee9adab1e63d5b5cd9faba6b9a92beef425 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.65e-05 | 179 | 133 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 180 | 133 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 180 | 133 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 133 | 6 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| Drug | Demecolcine | USP34 POLE UBR4 ZNFX1 MED13L WNK1 ZEB2 HNRNPD HEPH PLEKHG1 RIF1 FUT11 ATP8A1 SEC62 CFAP58 PRMT2 WDR90 ALPK2 | 2.94e-06 | 878 | 131 | 18 | ctd:D003703 |
| Disease | Malignant neoplasm of breast | ADAMTS19 ATP7B IDO1 NSD2 SYNE1 UBR4 OBSCN LAMA2 SIK3 ITGA9 WNK1 ADAM12 ZEB2 RIF1 ARID1B KMT2D GUCY2F EHMT1 HERC2 ZNF281 | 4.03e-08 | 1074 | 128 | 20 | C0006142 |
| Disease | pulse pressure measurement | USP34 BNC2 LAMA5 ST3GAL4 EBF1 MED13L ITGA9 HNF4G ADCY5 PLEKHG1 CILP2 ARID1B KIAA1549L ZNF516 FGF5 AKAP13 CTNND2 HYDIN MYBPC3 | 9.16e-06 | 1392 | 128 | 19 | EFO_0005763 |
| Disease | CHROMOSOME 6q24-q25 DELETION SYNDROME | 1.87e-05 | 2 | 128 | 2 | C3150215 | |
| Disease | cognitive function measurement | KNTC1 USP34 ZNF521 TMOD3 RFX6 SMC2 PLEKHG1 ARHGAP22 ARID1B KMT2D IPO9 NRXN1 TTLL2 CFAP58 BAIAP2 CTNND2 HYDIN MYBPC3 | 4.84e-05 | 1434 | 128 | 18 | EFO_0008354 |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.11e-04 | 4 | 128 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.11e-04 | 4 | 128 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.11e-04 | 4 | 128 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.11e-04 | 4 | 128 | 2 | 201300 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 1.51e-04 | 24 | 128 | 3 | DOID:3907 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | OBSCN ST3GAL4 GCKR ITGA9 TMEM106B CILP2 NPHP3 IPO9 PTPRJ LZTS1 AKAP13 ALPK2 MYBPC3 | 1.59e-04 | 904 | 128 | 13 | EFO_0004736 |
| Disease | Antihypertensive use measurement | 1.63e-04 | 265 | 128 | 7 | EFO_0009927 | |
| Disease | Abnormality of refraction | LAMA2 ST3GAL4 GCKR EBF1 ADCY5 ZNF462 TMEM106B ZNF516 DLG2 AKAP13 CTNND2 | 1.75e-04 | 673 | 128 | 11 | HP_0000539 |
| Disease | cardiovascular disease | 1.78e-04 | 457 | 128 | 9 | EFO_0000319 | |
| Disease | level of low-density lipoprotein receptor-related protein 11 in blood serum | 1.85e-04 | 5 | 128 | 2 | OBA_2042229 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | 1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) measurement | 1.85e-04 | 5 | 128 | 2 | EFO_0800454 | |
| Disease | glucose tolerance test | 2.16e-04 | 27 | 128 | 3 | EFO_0004307 | |
| Disease | lean body mass | 2.58e-04 | 379 | 128 | 8 | EFO_0004995 | |
| Disease | Corneal astigmatism | 3.58e-04 | 77 | 128 | 4 | EFO_1002040 | |
| Disease | urate measurement, bone density | PPFIBP1 SYNE1 LAMA5 GBE1 ARHGAP22 LZTS1 APRG1 ZNF516 DLG2 CTNND2 | 3.80e-04 | 619 | 128 | 10 | EFO_0003923, EFO_0004531 |
| Disease | retinal vasculature measurement | 4.39e-04 | 517 | 128 | 9 | EFO_0010554 | |
| Disease | red blood cell density measurement | STARD13 SP3 ST3GAL4 GCKR SIK3 WNK1 HNF4G ZEB2 ZNF462 ARID1B FGF5 AKAP13 | 4.61e-04 | 880 | 128 | 12 | EFO_0007978 |
| Disease | chronotype measurement | USP34 ZNF521 GBE1 MED13L HNF4G ADCY5 HNRNPD ZNF462 KMT2D NRXN1 PDZD8 TMEM123 | 4.70e-04 | 882 | 128 | 12 | EFO_0008328 |
| Disease | triacylglycerol 52:5 measurement | 4.71e-04 | 35 | 128 | 3 | EFO_0010417 | |
| Disease | alkaline phosphatase measurement | USP34 FBXW4 ST3GAL4 GCKR EBF1 ADCY5 TMEM106B CILP2 NPHP3 PTPRJ AKAP13 ALPK2 MYBPC3 | 4.82e-04 | 1015 | 128 | 13 | EFO_0004533 |
| Disease | body surface area | KNTC1 BNC2 GCKR MED13L WNK1 HNF4G ZNF462 GPR156 AKAP13 BAIAP2 | 5.11e-04 | 643 | 128 | 10 | EFO_0022196 |
| Disease | triacylglycerol 52:4 measurement | 5.13e-04 | 36 | 128 | 3 | EFO_0010416 | |
| Disease | breast cancer, ovarian carcinoma | 5.56e-04 | 37 | 128 | 3 | EFO_0001075, MONDO_0007254 | |
| Disease | kynurenine measurement | 6.50e-04 | 39 | 128 | 3 | EFO_0008529 | |
| Disease | vein graft stenosis | 6.59e-04 | 9 | 128 | 2 | EFO_0007051 | |
| Disease | Anorectal Malformations | 7.53e-04 | 41 | 128 | 3 | C3495676 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 8.21e-04 | 10 | 128 | 2 | OBA_2045163 | |
| Disease | blood urea nitrogen measurement | 8.22e-04 | 452 | 128 | 8 | EFO_0004741 | |
| Disease | Diuretic use measurement | 8.71e-04 | 169 | 128 | 5 | EFO_0009928 | |
| Disease | Alzheimer disease, APOE carrier status | 8.91e-04 | 98 | 128 | 4 | EFO_0007659, MONDO_0004975 | |
| Disease | Malignant neoplasm of salivary gland | 9.90e-04 | 45 | 128 | 3 | C0220636 | |
| Disease | thrombin generation potential measurement | 1.00e-03 | 11 | 128 | 2 | EFO_0005538 | |
| Disease | level of Ceramide (d40:1) in blood serum | 1.00e-03 | 11 | 128 | 2 | OBA_2045185 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 1.00e-03 | 11 | 128 | 2 | OBA_2045170 | |
| Disease | non-melanoma skin carcinoma | 1.08e-03 | 265 | 128 | 6 | EFO_0009260 | |
| Disease | Salivary Gland Neoplasms | 1.12e-03 | 47 | 128 | 3 | C0036095 | |
| Disease | body weight | KNTC1 MGAM VPS13C ZNF521 GCKR EBF1 HNF4G ADCY5 ADCY6 IPO9 NRXN1 PTPRJ DLG2 BAIAP2 | 1.17e-03 | 1261 | 128 | 14 | EFO_0004338 |
| Disease | phosphatidylcholine 34:4 measurement | 1.20e-03 | 12 | 128 | 2 | EFO_0010378 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 1.20e-03 | 12 | 128 | 2 | OBA_2045171 | |
| Disease | visceral adipose tissue measurement | 1.22e-03 | 481 | 128 | 8 | EFO_0004765 | |
| Disease | tumor necrosis factor ligand superfamily member 8 measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0010592 | |
| Disease | sterol measurement | 1.41e-03 | 13 | 128 | 2 | EFO_0010231 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.41e-03 | 13 | 128 | 2 | C0270914 | |
| Disease | Hypermetropia, Myopia | 1.43e-03 | 189 | 128 | 5 | HP_0000540, HP_0000545 | |
| Disease | Myopia | 1.49e-03 | 385 | 128 | 7 | HP_0000545 | |
| Disease | birth weight, parental genotype effect measurement | 1.54e-03 | 192 | 128 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | actinic keratosis | 1.64e-03 | 14 | 128 | 2 | EFO_0002496 | |
| Disease | body weights and measures, parental genotype effect measurement | 1.64e-03 | 14 | 128 | 2 | EFO_0004324, EFO_0005939 | |
| Disease | Left ventricular noncompaction | 1.64e-03 | 14 | 128 | 2 | C1960469 | |
| Disease | keratinocyte carcinoma | 1.77e-03 | 118 | 128 | 4 | EFO_0010176 | |
| Disease | facial morphology | 1.77e-03 | 55 | 128 | 3 | EFO_0004743 | |
| Disease | cancer | 1.85e-03 | 400 | 128 | 7 | MONDO_0004992 | |
| Disease | isoleucine measurement | 1.87e-03 | 56 | 128 | 3 | EFO_0009793 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.87e-03 | 56 | 128 | 3 | EFO_0022235 | |
| Disease | Lymphoma, Follicular, Grade 2 | 1.89e-03 | 15 | 128 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 1.89e-03 | 15 | 128 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 1.89e-03 | 15 | 128 | 2 | C1956130 | |
| Disease | triacylglycerol 52:3 measurement | 1.89e-03 | 15 | 128 | 2 | EFO_0010415 | |
| Disease | Lymphoma, Large-Cell, Follicular | 1.89e-03 | 15 | 128 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 1.89e-03 | 15 | 128 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 1.89e-03 | 15 | 128 | 2 | C0079758 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 1.89e-03 | 15 | 128 | 2 | OBA_2045165 | |
| Disease | Alzheimer disease, Cognitive impairment | 1.89e-03 | 15 | 128 | 2 | HP_0100543, MONDO_0004975 | |
| Disease | body fat distribution | 1.92e-03 | 202 | 128 | 5 | EFO_0004341 | |
| Disease | Hypertrophic Cardiomyopathy | 1.97e-03 | 57 | 128 | 3 | C0007194 | |
| Disease | diet measurement | MGAM BNC2 KDM3B LAMA2 ZNF521 GBE1 GCKR EBF1 SMC2 ARID1B DLG2 CTNND2 | 2.07e-03 | 1049 | 128 | 12 | EFO_0008111 |
| Disease | triacylglycerol 50:5 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0010412 | |
| Disease | phosphatidylcholine 32:2 measurement | 2.15e-03 | 16 | 128 | 2 | EFO_0010374 | |
| Disease | reaction time measurement | 2.35e-03 | 658 | 128 | 9 | EFO_0008393 | |
| Disease | hair color | 2.42e-03 | 311 | 128 | 6 | EFO_0003924 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.43e-03 | 17 | 128 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Breast Carcinoma | 2.46e-03 | 538 | 128 | 8 | C0678222 | |
| Disease | lysophosphatidylcholine measurement | 2.50e-03 | 62 | 128 | 3 | EFO_0010224 | |
| Disease | Meckel syndrome type 1 | 2.73e-03 | 18 | 128 | 2 | C3714506 | |
| Disease | ovarian neoplasm | 2.81e-03 | 134 | 128 | 4 | C0919267 | |
| Disease | alcohol consumption measurement | MGAM ZNF521 GBE1 RFX6 GCKR SPTBN5 IPO9 NRXN1 PTPRJ ZNF516 WDR90 CTNND2 MYBPC3 | 2.94e-03 | 1242 | 128 | 13 | EFO_0007878 |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 2.99e-03 | 66 | 128 | 3 | EFO_0007708 | |
| Disease | breast carcinoma (is_marker_for) | 2.99e-03 | 66 | 128 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Malignant neoplasm of ovary | 3.04e-03 | 137 | 128 | 4 | C1140680 | |
| Disease | cardiomyopathy (is_implicated_in) | 3.04e-03 | 19 | 128 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | squamous cell carcinoma | 3.12e-03 | 67 | 128 | 3 | EFO_0000707 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.20e-03 | 139 | 128 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 3.20e-03 | 139 | 128 | 4 | C0007621 | |
| Disease | phospholipid measurement | 3.29e-03 | 140 | 128 | 4 | EFO_0004639 | |
| Disease | sporadic amyotrophic lateral sclerosis | 3.29e-03 | 140 | 128 | 4 | EFO_0001357 | |
| Disease | forced expiratory volume, response to bronchodilator | 3.35e-03 | 445 | 128 | 7 | EFO_0004314, GO_0097366 | |
| Disease | cortical thickness | BNC2 PPFIBP1 LAMA2 EBF1 ADAM12 HNF4G HNRNPD ZNF462 PLEKHG1 TMEM106B CELSR1 ARID1B | 3.36e-03 | 1113 | 128 | 12 | EFO_0004840 |
| Disease | Craniosynostosis | 3.37e-03 | 20 | 128 | 2 | C0010278 | |
| Disease | Lymphoma, Follicular | 3.37e-03 | 20 | 128 | 2 | C0024301 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.39e-03 | 69 | 128 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | congenital heart disease (implicated_via_orthology) | 3.39e-03 | 69 | 128 | 3 | DOID:1682 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.44e-03 | 447 | 128 | 7 | C3714756 | |
| Disease | total blood protein measurement | 3.52e-03 | 449 | 128 | 7 | EFO_0004536 | |
| Disease | Colorectal Carcinoma | 3.60e-03 | 702 | 128 | 9 | C0009402 | |
| Disease | apolipoprotein A 1 measurement | MGAM RFX6 ST3GAL4 GCKR EBF1 SIK3 ADCY5 TMEM106B CDH16 MYBPC3 | 3.94e-03 | 848 | 128 | 10 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAMGSQGNLSAEVEQ | 61 | O95670 | |
| MAGQLQAATHQGSGA | 81 | Q9ULZ3 | |
| EMAQHTGQLVLQNGF | 171 | P55345 | |
| NDGGAVVNDMSHDNH | 661 | Q6ZN30 | |
| SNDGNMGHEAEIQPA | 1436 | Q86TB3 | |
| SNDVTLANHMEAGGR | 496 | O43306 | |
| LGNHSAGNSMVQTTD | 436 | P35670 | |
| HSSEAAIMNNSQGDG | 191 | Q96G28 | |
| AIMNNSQGDGEHFAH | 196 | Q96G28 | |
| STAAELQHGMGNTSL | 851 | Q12802 | |
| TADQSGGIVMDHSDN | 326 | O43184 | |
| MNLLAIQHQATGSAG | 116 | Q8IY63 | |
| DTAQAMENGLVSLHA | 236 | Q6MZZ7 | |
| ELNMAHNAGAAAAAG | 81 | Q8NFD5 | |
| ANAEQMGLQGSAQHF | 51 | Q8IVJ8 | |
| HLNGVAMNVRTGSAQ | 2991 | Q9NYQ6 | |
| SNDVTLANHMEAGGK | 586 | O95622 | |
| DAVINHMSGNAVSAG | 111 | P19961 | |
| EDGMQAQHLGATLAL | 431 | Q7Z478 | |
| QHGADSENGDMNSSV | 361 | Q9UI36 | |
| AAETSQGQHMGTDEL | 776 | Q9UQB3 | |
| DGANDVSMIQTAHVG | 801 | Q9Y2Q0 | |
| MHLNNGNFSSEEEDA | 76 | Q8HWS3 | |
| DNGLNLAFTIAHEMG | 471 | Q8TE59 | |
| MASASARGNQDKDAH | 1 | Q56VL3 | |
| MVNNGSDQHGSQFLI | 96 | Q8WUA2 | |
| AQRMNSHGGFSSNQV | 1011 | Q6IE37 | |
| IGVNESIHNMGNGLS | 296 | Q9NP74 | |
| SIHNMGNGLSEERGN | 301 | Q9NP74 | |
| QTAGGGHAAQFLQDM | 281 | P14902 | |
| SFQMHITQEGAGNSR | 481 | Q12913 | |
| IQSGLSQMGNLHAFA | 521 | Q5TKA1 | |
| DNDIGILMTGNLHSS | 2036 | Q71F56 | |
| QGHDQMSSGFQHERL | 516 | Q9Y250 | |
| GSAHGVLLLNSNAMD | 1136 | Q2M2H8 | |
| TMGEQNRSADGQHAG | 206 | P30989 | |
| NHKEEMSQLTGQNSG | 291 | P35527 | |
| QIGAFSEGINNLTHM | 971 | Q86W92 | |
| QHGANNLDLLLNSGM | 1796 | O95714 | |
| QGSGLSMDQHSNIRD | 136 | Q5T655 | |
| GSAHGVLLLNSNAMD | 2076 | O43451 | |
| GENTLNGHEKETMQF | 96 | O76015 | |
| MAENTEGDLNSNLLH | 1 | Q6PCE3 | |
| VGQMGLTENKHSFQD | 831 | Q8NEN9 | |
| MHADAQNLGAVASSG | 141 | A8MUP2 | |
| LEDAANKSSGHMQTQ | 731 | Q1MSJ5 | |
| SLQEGVMQKFNGHDA | 56 | O96028 | |
| NGESMAGLTHQDALQ | 271 | Q14005 | |
| MDLQAAGAQAQGAAE | 1 | Q9NQ92 | |
| SQHVNGGVMNGLEQS | 1546 | P48681 | |
| ANGLHLFQMGTDSQN | 151 | Q7LBC6 | |
| HNTNAGQGQGDASMD | 1471 | P50748 | |
| SGMASVVSNQNHNDG | 2406 | P24043 | |
| MDHTASQNAQDLIGI | 1 | Q6ZVL6 | |
| AAVHGLSMQQEIGFQ | 376 | Q07864 | |
| ELMSQTGHLGLANAS | 2291 | O15230 | |
| DDQQAMTGQMAGDHT | 826 | Q9ULB1 | |
| MGANVSQDNGTGHNA | 21 | P48146 | |
| DAGNHASMIQGIRNS | 281 | P22557 | |
| LQEMLLGGASNDGSH | 321 | Q14541 | |
| AANTKGDQEQAMLHA | 366 | Q86VI3 | |
| FGSAMAHLGDLNQDG | 386 | P53708 | |
| TAMQAASQNGHVDIL | 466 | Q86YT6 | |
| GDHSDMFNQKAELTN | 366 | Q14397 | |
| MDHTDNELQGTNSSG | 1 | Q75N03 | |
| HNEVQAEAGASAMLS | 1081 | Q5VST9 | |
| AMAASANIENSGLPH | 31 | Q8N131 | |
| NGQTMNEKQLFHGTD | 1671 | Q460N5 | |
| DGKVNGSHEANMLSV | 106 | P12034 | |
| NRLSSGGAEMFHVQE | 831 | Q13797 | |
| HASKNSADGLNMFDG | 291 | Q04446 | |
| QGSAQKDQLSQGTMH | 3856 | Q4G0P3 | |
| QGLDQGEALTAMIHN | 456 | Q495W5 | |
| GQAGAASLVQHSRNM | 371 | P51841 | |
| MQGAGVLDANTAAQS | 31 | Q9UH73 | |
| DLNSGQLMTHLGSDF | 276 | P57775 | |
| TLHTDDNATMQNGGE | 701 | Q96P70 | |
| SGHLSDFQNDPGMAA | 426 | Q8NFN8 | |
| QLENLGTHGTMDLNN | 146 | Q9NYL5 | |
| MENHLLSGNNGTLEY | 301 | Q15700 | |
| QAEAAGGEAAAMLHN | 236 | Q9Y666 | |
| KQAGEAHMAADGETN | 41 | Q9H9B1 | |
| MGDQASGHQATATVE | 216 | O75309 | |
| SMGSGDHQFNLAEIL | 36 | Q8N344 | |
| QEGAMVAATQGAAAA | 26 | Q14103 | |
| LNLVAHANGGFSVDM | 151 | P17600 | |
| MRNGLVNSEVHNEDG | 26 | Q9NUM4 | |
| DLNENLAAAQGLAHM | 846 | Q9Y3M8 | |
| HEGGSRSENVDMNSN | 21 | O75159 | |
| QHTAMNDAGNFLIET | 656 | Q8NF91 | |
| NFSDDSGISGLRNHM | 61 | Q9NYJ8 | |
| METFQQASNSAHELG | 491 | Q7Z494 | |
| NSDQTFHLMSNLAGD | 401 | Q9H6L5 | |
| TMELNVGNEASFHGQ | 1916 | Q5UIP0 | |
| VHMLDNNTGSGNETG | 51 | Q63ZE4 | |
| IEGFQDSNRMHAING | 611 | Q9BQS7 | |
| LKSMAGSGHNVSQEA | 301 | Q11206 | |
| GGILNNSHMGQEIDS | 371 | Q9NSC7 | |
| QELFRHMNQGDAGSL | 1016 | Q9Y2K2 | |
| EGQQLVDNSHFMSAE | 3376 | Q9NRC6 | |
| HQMAVIGQQAGSSSN | 476 | P11831 | |
| LDHSMDEAGAGASNS | 566 | Q7Z5H3 | |
| SAMINSNDDNGVLAG | 221 | Q08188 | |
| DSDGSDRLHMSLQQG | 436 | Q9UQB8 | |
| AQMDGFSAGEAQAQA | 261 | Q8IUL8 | |
| LSSGDQSHKMGDNAS | 621 | Q92618 | |
| QSHKMGDNASERDTG | 626 | Q92618 | |
| AMGTAQDFAGHDNAV | 1706 | Q96KV7 | |
| GTGGSDVLQMQNSEH | 31 | Q9ULM2 | |
| DRSQHSSGNGNDFEM | 351 | Q99442 | |
| MHNTGATDLQGNDFD | 71 | Q7RTT5 | |
| MTAGINADGHLINTG | 286 | Q02447 | |
| NADGHLINTGQAMDS | 291 | Q02447 | |
| MGAISQANINLIGSH | 406 | Q9H0I9 | |
| MQVHERNKDGSQSGS | 221 | Q96K83 | |
| SGGFMALQQHLADIN | 431 | Q9NUY8 | |
| GSSNHTNMGNLAVLS | 381 | Q9Y2X9 | |
| NMQAGDTILNSNHIG | 156 | Q5T653 | |
| GHLDSMNVSLNQEDL | 1346 | Q709C8 | |
| SQLEGEMSGQDFHLS | 486 | Q9BWV7 | |
| DAALDLSHTQNIGQM | 1116 | O95347 | |
| SNQLASEMDGAQHAA | 1886 | Q9P2E3 | |
| DSENGLSAMDHQTSG | 396 | Q96JM2 | |
| HQTSGLSAEQLMGSD | 406 | Q96JM2 | |
| SNSHMGLFNQDKEVG | 36 | Q9ULL1 | |
| SGEMNATHIAQGSQE | 706 | Q70CQ2 | |
| AHSDVASGMSDGNEN | 1071 | Q9H4A3 | |
| GTDQHQMLTQGAGNR | 266 | O60315 | |
| LSMNQTLEGHSGSVQ | 61 | Q9P2L0 | |
| MATLASAGQGAGHLQ | 1541 | Q5T4S7 | |
| MQAHKNALGTSGEQQ | 6 | Q9NQA3 | |
| SHVMKGINLSSGDQN | 1481 | P18583 | |
| NIMGSSNGVDQEHFS | 151 | Q9NYL9 | |
| GNSSSNMNIRGDTGH | 131 | Q8NDP4 | |
| NGQSLNHGMALTIHN | 301 | Q86TJ5 | |
| QQGSMAGLSHLQQSL | 3866 | O14686 | |
| AQNAIAGEGMGISHE | 146 | P20591 | |
| INHSIAMQNGKVDGS | 81 | Q9NPC6 | |
| NFNLTVHEAMGTGDL | 251 | Q14896 |